Low Fibrinogen Control
Intended use: Provides a reliable marker in the abnormal range. Recommended for a complete quality control program on IL’s ACL and ELECTRA Systems.
Principle: Contains human plasma with a reduced level of fibrinogen (approximately 100 mg/dL or 1 g/L). Fibrinogen, a plasma protein, is converted to fibrin by the action of thrombin. The use of a quantitative fibrinogen control is essential in monitoring the accuracy and precision of the fibrinogen assay system.
CE Mark:
510(k):
Vials and volumes:
10 x 1 mL Low Fibrinogen Control (lyo)
Part number:
0020004200
Main features:
Principle: Contains human plasma with a reduced level of fibrinogen (approximately 100 mg/dL or 1 g/L). Fibrinogen, a plasma protein, is converted to fibrin by the action of thrombin. The use of a quantitative fibrinogen control is essential in monitoring the accuracy and precision of the fibrinogen assay system.
CE Mark:
510(k):
Vials and volumes:
10 x 1 mL Low Fibrinogen Control (lyo)
Part number:
0020004200
Main features:
- Abnormal control assigned using the PT-based method
- Abnormal control assigned using the Clauss method
- Traceability versus the NIBSC Standards (according to WHO recommendations)
